Volume 13, Issue 4 (Winter 2016)                   Sci J Iran Blood Transfus Organ 2016, 13(4): 284-290 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Azami M, Nikpey S, Borji ., Ghasemi Pashaklaee E. Determination of the frequency of prophylaxis utilization against deep vein thrombosis among patients hospitalized in surgical wards of Imam Khomeini Teaching Hospital. Sci J Iran Blood Transfus Organ 2016; 13 (4) :284-290
URL: http://bloodjournal.ir/article-1-997-en.html
Determination of the frequency of prophylaxis utilization against deep vein thrombosis among patients hospitalized in surgical wards of Imam Khomeini Teaching Hospital
M. Azami , S. Nikpey , .M Borji , E. Ghasemi Pashaklaee *
Keywords: Key words: prophylaxis, Deep Vein Thrombosis, Hospitals
Full-Text [PDF 259 kb]   (1317 Downloads)     |   Abstract (HTML)  (5067 Views)
Full-Text:   (2415 Views)
References:
 
  1. Geerts WH, Pineo GF, Heit JA, Berggvist D, Lassen MR, Colwell CW, et al. Prevention of venous thromboembolism: the Seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126(3 Suppl): 338S-400S.
  2. Sharif-Kashani B, Mohebi-Nejad A, Abooturabi M. Estimated Prevalence of Venous Thromboembolism in Iran: Prophylaxis Still an Unmet Challenge. Tanaffos 2015; 14(1): 27-33.
  3. Geersing GJ, Zuithoff NP, Kearon C, Anderson DR, Ten Cate-Hoek AJ, Elf JL, et al. Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis. BMJ 2014; 348: g1340.
  4. Lim YP, Lin CL, Hung DZ, Ma WC, Lin YN, Kao CH. Increased Risk of Deep Vein Thrombosis and Pulmonary Thromboembolism in Patients With Organophosphate Intoxication: A Nationwide Prospective Cohort Study. Medicine (Baltimore) 2015; 94(1): e341.
  5. SooHoo NF, Eagan M, Krenek L, Zingmond DS. Incidence and factors predicting pulmonary embolism and deep venous thrombosis following surgical treatment of ankle fractures. Foot Ankle Surg 2011; 17(4): 259-62.
  6. van Stralen KJ, Rosendaal FR, Doggen CJ. Minor injuries as a risk factor for venous thrombosis. Arch Intern Med 2008; 168(1): 21-6.
  7. Ro A, Kageyama N, Fukunaga T. Significance of the soleal vein for the pathogenesis of deep vein thrombosis leading to acute massive pulmonary thromboembolism. Masui 2007; 56(7): 801-7. [Article in Japanese]
  8. Alikhan R, Bedenis R, Cohen AT. Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction). Cochrane Database Syst Rev 2014; 5: CD003747.
  9. Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ, et al. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004; 110(7): 874-9.
  10. Boneu B, Caranobe C, Cadroy Y, Dol F, Gabaig AM, Dupouy D, et al. Pharmacokinetic studies of standard unfractionated heparin, and lowmolecular weight heparins. Semin Thromb Hemost 1988; 14(1): 18-27.
  11. Joint Commission on Accreditation of Healthcare Organizations. National consensus standards for prevention and care of venous thromboembolism (VTE); 2007. Available from: http://www.jointcommission.org/.
  12. Cohen AT, Tapson VF, Bergmann JF, Goldhaber
    SZ    , Kakkar AK, Deslandes B, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008; 371(9610): 387-94.
  13. Pinjala R; ENDORSE-India investigators. Venous thromboembolism risk & prophylaxis in the acute hospital care setting (ENDORSE) a multinational cross-sectional study: Results from the Indian subset data. Indian J Med Res 2012; 136(1): 60-7.
  14. França A, Reis A, Paulino A, Lohman C, Cartucho D, Campello G, et al. Venous thromboembolism risk factors and practices of prophylaxis: ENDORSE study results in Portugal. Acta Med Port 2011; 24(6): 951-60.
  15. Musiał J, Sydor WJ; ENDORSE Investigators-Poland. Venous thromboembolism risk and prophylaxis in the acute hospital care setting--results of the ENDORSE study in Poland. Pol Arch Med Wewn 2008; 118(10): 555-61.
  16. Amin A, Spyropoulos AC, Dobesh P, Shorr A, Hussein M, Mozaffari E, et al. Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start). J Thromb Thrombolysis 2010; 29(3): 326-39.
  17. Hoseini Nasab AR, Zahmatkesh MM. Evaluation the rate of the preventive measurment for venous thromboembolism in surgical ward of a private hospital in Tehran. RJMS 2002; 9(29): 216-23. [Article in Farsi]
  18. Khavaninzadeh M, Mousavi Vaeezi S, Ramezaniyan Nik E, Reza Gharebagh K. Determination of the frequency of prophylaxis usage against deep-vein thrombosis in hospitalized patients admitted in an educational hospital. Razi Journal of Medical Sciences 2013; 19(104): 78-82. [Article in Farsi]
  19. Nutescu EA. Assessing, preventing, and treating venous thromboembolism: evidence-based approaches. Am J Health Syst Pharm 2007; 64(11 Suppl 7): S5-13.
  20. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, et al. Prevention of venous thromboembolism. Chest 2001; 119(1 Suppl): 132S-175S.
  21. Leme LE, Sguizzatto GT. PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN ORTHOPAEDIC SURGERY. Rev Bras Ortop 2015; 47(6): 685-93.
  22. Piazza G, Seddighzadeh A, Goldhaber SZ. Double trouble for 2,609 hospitalized medical patients who developed deep vein thrombosis: prophylaxis omitted more often and pulmonary embolism more frequent. Chest 2007; 132(2): 554-61.
 
 

 
 
 
 
 
 
 
 
Sci J Iran Blood Transfus Organ 2017; 13(4): 284-290
Original Article
 
 

Determination of the frequency of prophylaxis utilization against deep vein thrombosis among patients hospitalized
in surgical wards of Imam Khomeini
Teaching Hospital
 
Azami M.1, Nikpay S.1, Borji M.1, Ghasemi Pashaklaee E.2
 
1Student Research Committee, Ilam University of Medical Sciences, Ilam, Iran
2Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran
 
Abstract
Background and Objectives
The current survey aims at determining the frequency of prophylaxis usage against deep vein thrombosis (DVT) according to ACCP instruction among the patients hospitalized in surgical wards of Imam Khomeini teaching hospital in Ilam.
 
Materials and Methods
This study is descriptive and retrospective and the sampling was carried out amongst the cases of patients who were hospitalized and underwent operation in the period between March of 2012 to September of 2013 in Imam Khomeini Hospital in Ilam. The type of receiving Prophylaxis was determined by ACCP (The American College of Chest Physicians) Guidelines. After investigating the input and output criteria, patients’ data were extracted according to the dependent variables. Eventually the information gathered from the cases were analyzed by SPSS software version 17.
 
Results
There were 169 qualified cases out of whom 46.2% (78 participants) were female. Out of 132 patients in need, only 39 persons (29.5%) were offered Prophylaxis. ACCP Guidelines with respect to the appropriate type, dose, and duration of thromboprophylaxis were followed completely only in 30 individuals (22.5%). The maximum rate of thrombo-prophylaxis happened to be in ICU (46.6%) and neurosurgery section (47.5%) and the least utilization of that was in the kidney and urinary tract section (0%).
 
Conclusions 
This study shows that there is a considerable difference in the clinical performance recommended by ACCP in prophylaxis against DVT; in 75% of DVT affected patients, thrombo-prophylaxis was not offered according to ACCP Guidelines. Thus, new strategies must be implemented to operate thrombo-prophylaxis against DVT in Ilam hospitals.
 
Key words: prophylaxis, Deep Vein Thrombosis, Hospitals
 
 
 
 
 
Received: 23 Nov 2015
Accepted: 28 Jun 2016
 
 

Correspondence: Ghasemi Pashaklaee E., MD. Pulmonary Specialist. Assiatant Professor of Faculty of Medicine, Ilam University of Medical Sciences. Pazhuhesh Blv.
Postal Code: 6939177143, Ilam, Iran. Tel: (+9884) 33368700; Fax: (+9884) 33368700
                E-mail: smaeilghasemi@yahoo.com
Type of Study: Research | Subject: Hematology
Published: 2016/12/24
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Scientific Journal of Iran Blood Transfus Organ

Designed & Developed by : Yektaweb